Litao Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Litao Cai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Fuxing Pei
Department of Orthopaedics and Orthopaedic Research Institute, West China Hospital, Sichuan University, Chengdu, People's Republic of China
1 shared publication - Guorui Cao
Orthopaed Hosp Henan Prov, Luoyang Orthoped Traumatol Hosp Henan Prov, Dept Knees Osteoarthropathy, 82 Qimingnan Rd Henan Prov, Luoyang 471002, Peoples R China
1 shared publication - Hong Xu
Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
1 shared publication - Honglue Tan
Department of Knee Injury Luoyang Orthopedic Hospital of Henan Province Orthopedic Hospital of Henan Province Luoyang Henan Province People's Republic of China
1 shared publication - Junna Yao
Department of Knee Surgery, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, People’s Republic of China
1 shared publication - Shaoyun Zhang
Department of Orthopedics, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 15 May 2023
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 24 (1) , 1-6
The efficacy and safety of tranexamic acid in rheumatoid arthritis patients undergoing simultaneous bilateral total knee arthroplasty: a multicenter retrospective study
Background: The efficacy and safety of tranexamic acid (TXA) in reducing blood loss following total knee arthroplasty (TKA) in patients with osteoarthritis have been widely confirmed. However, there is still a paucity of the evidences regarding the effectiveness of TXA in patients with rheumatoid arthritis (RA). The purpose of the study is to explore the efficacy and safety of intravenous TXA on blood loss and transfusion risk following simultaneous bilateral TKA (SBTKA) in patients with RA. Methods: As a multicenter retrospective study, a total of 74 patients diagnosed with RA who underwent SBTKA were assigned into TXA group (15 mg/kg intravenous TXA before skin incision, n = 50) and control group (no TXA use, n = 24). The primary outcomes were total blood loss (TBL) and intraoperative blood loss (IBL). The secondary outcomes were hemoglobin (Hb) and hematocrit (Hct) drop on postoperative day 3, transfusion rate and volume, ambulation time, length of stay, hospitalization expenses and the incidence of complications. Results: The mean TBL, IBL and transfusion volume in TXA group were significantly lower than those in control group. The Hb and Hct drop on postoperative day 3 in control group were higher than those in TXA group (p0.05). Conclusions: TXA could effectively reduce blood loss, decrease transfusion risk, shorten ambulation time and length of stay following SBTKA in patients with RA, without increasing the risk of complications.
- 15 May 2023
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 24 (1) , 1-6
Open AccessThe efficacy and safety of tranexamic acid in rheumatoid arthritis patients undergoing simultaneous bilateral total knee arthroplasty: a multicenter retrospective study
Background: The efficacy and safety of tranexamic acid (TXA) in reducing blood loss following total knee arthroplasty (TKA) in patients with osteoarthritis have been widely confirmed. However, there is still a paucity of the evidences regarding the effectiveness of TXA in patients with rheumatoid arthritis (RA). The purpose of the study is to explore the efficacy and safety of intravenous TXA on blood loss and transfusion risk following simultaneous bilateral TKA (SBTKA) in patients with RA. Methods: As a multicenter retrospective study, a total of 74 patients diagnosed with RA who underwent SBTKA were assigned into TXA group (15 mg/kg intravenous TXA before skin incision, n = 50) and control group (no TXA use, n = 24). The primary outcomes were total blood loss (TBL) and intraoperative blood loss (IBL). The secondary outcomes were hemoglobin (Hb) and hematocrit (Hct) drop on postoperative day 3, transfusion rate and volume, ambulation time, length of stay, hospitalization expenses and the incidence of complications. Results: The mean TBL, IBL and transfusion volume in TXA group were significantly lower than those in control group. The Hb and Hct drop on postoperative day 3 in control group were higher than those in TXA group (p0.05). Conclusions: TXA could effectively reduce blood loss, decrease transfusion risk, shorten ambulation time and length of stay following SBTKA in patients with RA, without increasing the risk of complications.